Anupam Rasayan India Limited

ANURAS

INE930P01018

Specialty Chemicals

Market Closed - NSE India S.E. Other stock markets 07:42:29 2024-04-30 am EDT			5-day change	1st Jan Change
832.6 ^INR	+0.14%		-2.22%	-20.86%

Apr. 03	Anupam Rasayan Signs LOI Worth $90 Million with Japanese Multinational Company	MT
Apr. 02	Anupam Rasayan India Limited Signs LOI with Prominent Japanese Multinational Worth $90 Million	CI

Anupam Rasayan India Ltd Announces Resignation of Milan Ramesh Thakkar as Non-Executive Non-Independent Director

November 06, 2023 at 08:51 am EST

Anupam Rasayan India Ltd. announced that Mr. Milan Ramesh Thakkar vide his letter dated November 06, 2023, has tendered his resignation from the position of Non-Executive Non-Independent Director of the Company, with immediate effect i.e. November 06, 2023, due to his pre-occupations and other personal commitments.

Latest news about Anupam Rasayan India Limited

Anupam Rasayan Signs LOI Worth $90 Million with Japanese Multinational Company	Apr. 02	MT
Anupam Rasayan India Limited Signs LOI with Prominent Japanese Multinational Worth $90 Million	Apr. 02	CI
40,486,470 Equity Shares of Anupam Rasayan India Ltd are subject to a Lock-Up Agreement Ending on 21-MAR-2024.	Mar. 20	CI
Anupam Rasayan India Forms New US Subsidiary	Feb. 28	MT
Anupam Rasayan India Limited Announces Intimation of Registration of A Wholly Owned Subsidiary in Delaware, USA	Feb. 28	CI
Jefferies Adjusts Anupam Rasayan India’s Price Target to INR565 From INR960, Keeps at Underperform	Feb. 13	MT
Transcript : Anupam Rasayan India Limited, Q3 2024 Earnings Call, Feb 12, 2024	Feb. 12
Anupam Rasayan India Limited Appoints Link Intime India Pvt. Ltd. as Registrar and Share Transfer Agent	Feb. 12	CI
Anupam Rasayan India Limited Approves Set-Up of Hybrid Power Plant of A Total Capacity of 9.6 Mw in Bharuch, Gujarat	Feb. 11	CI
Anupam Rasayan India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 11	CI
Anupam Rasayan India Ltd announced that it has received INR 2.724999276 billion in funding from Zeal Global Opportunities Fund, Zinnia Global Fund PCC, Rehash Industrial and Resins Chemicals Private Limited	Jan. 22	CI
Anupam Rasayan India Forms New Wholly-Owned Arm in Switzerland	Jan. 21	MT
Anupam Rasayan India Ltd Signs Letter of Intent Worth Revenue of $61 million	Dec. 25	CI
Anupam Rasayan India Limited Approves Appointment of Anuj Hemantbhai Thakar as A Whole-Time Director	Dec. 08	CI
Anupam Rasayan Incorporates Wholly-Owned Subsidiary in Japan	Dec. 06	MT
Jefferies Adjusts Anupam Rasayan India’s Price Target to INR825 From INR860, Keeps at Underperform	Nov. 08	MT
Transcript : Anupam Rasayan India Ltd, Q2 2024 Earnings Call, Nov 07, 2023	Nov. 07
Anupam Rasayan India Ltd Declares First Interim Dividend for the Financial Year 2023-2024, Payable on or Before December 05, 2023	Nov. 07	CI
Anupam Rasayan India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 07	CI
Anupam Rasayan India Ltd announced that it expects to receive INR 2.724999276 billion in funding from Zeal Global Opportunities Fund, Zinnia Global Fund PCC, Rehash Industrial and Resins Chemicals Private Limited	Nov. 06	CI
Anupam Rasayan India Ltd Announces Resignation of Milan Ramesh Thakkar as Non-Executive Non-Independent Director	Nov. 06	CI
Anupam Rasayan India Limited Signs Three Memorandum of Understanding with Government of Gujarat	23-09-26	CI
Anupam Rasayan Names CEO	23-09-07	MT
Anupam Rasayan India Ltd Appoints Ashish Gupta as Company Secretary and Compliance Officer	23-09-07	CI
Anupam Rasayan India Ltd Appoints Gopal Agrawal as Chief Executive Officer, with Effect from September 11, 2023	23-09-07	CI

Chart Anupam Rasayan India Limited

Duration

Period

More charts

Company Profile

Anupam Rasayan India Limited is engaged in the custom synthesis and manufacturing of specialty chemicals in India. The Companyâs segments include Life Science Related Specialty Chemicals and Other Specialty Chemicals. It manufactures a variety of life science related specialty chemicals comprising products related to agrochemicals, personal care, and pharmaceuticals. The Company manufactures agro intermediates and agro active ingredients for the agrochemicals industry, which are used in the manufacture of, amongst others, insecticides, fungicides, and herbicides. For the personal care industry, it provides, amongst others, anti-bacterial and ultraviolet protection intermediates, and ingredients. In the pharmaceutical segment, the Company focuses on developing intermediates and key starting materials for active pharmaceutical ingredients. The Companyâs other specialty chemicals are used in diverse end-user segments, comprising specialty pigments, specialty dyes and polymer additives.

Sector

Specialty Chemicals

Calendar

2024-06-09 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Anupam Rasayan India Limited

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

832.6 INR

Average target price

823 INR

Spread / Average Target

-1.15%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
ANUPAM RASAYAN INDIA LIMITED	-20.86%	1.09B
ECOLAB INC.	+14.73%	63.38B
SIKA AG	-3.80%	46.51B
GIVAUDAN SA	+13.26%	39.91B
FUJIFILM HOLDINGS CORPORATION	+19.57%	25.57B
EMS-CHEMIE HOLDING AG	+8.22%	18.95B
CELANESE CORPORATION	-0.57%	17.58B
POSCO FUTURE M CO., LTD.	-21.03%	16.1B
SYMRISE AG	+1.06%	14.98B
ALBEMARLE CORPORATION	-16.84%	14.78B

Other Specialty Chemicals

Anupam Rasayan India Limited

Equities

ANURAS

INE930P01018

Specialty Chemicals

Anupam Rasayan India Ltd Announces Resignation of Milan Ramesh Thakkar as Non-Executive Non-Independent Director

Latest news about Anupam Rasayan India Limited

Chart Anupam Rasayan India Limited

Company Profile

Income Statement Evolution

Ratings for Anupam Rasayan India Limited

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Specialty Chemicals